fr
Article scientifique
Anglais

Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study

Collaborateurs/tricesChizzolini, Carlo
Publié dansArthritis and Rheumatology, vol. 70, no. 11, p. 1829-1834
Date de publication2018
Résumé

Data on the role of tobacco exposure in systemic sclerosis (SSc; scleroderma) severity and progression are scarce. We aimed to assess the effects of smoking on the evolution of pulmonary and skin manifestations, based on the European Scleroderma Trials and Research group database.

Mots-clés
  • Adult
  • Aged
  • Autoantibodies/immunology
  • DNA Topoisomerases/immunology
  • Disease Progression
  • Ex-Smokers
  • Female
  • Forced Expiratory Volume
  • Humans
  • Linear Models
  • Logistic Models
  • Longitudinal Studies
  • Lung/physiopathology
  • Male
  • Middle Aged
  • Non-Smokers
  • Scleroderma
  • Systemic/immunology/pathology/physiopathology
  • Severity of Illness Index
  • Skin/pathology
  • Smokers
  • Smoking/immunology/pathology/physiopathology
  • Vital Capacity
Citation (format ISO)
JAEGER, Veronika K et al. Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study. In: Arthritis and Rheumatology, 2018, vol. 70, n° 11, p. 1829–1834. doi: 10.1002/art.40557
Fichiers principaux (1)
Article (Published version)
accessLevelRestricted
Fichiers secondaires (1)
Identifiants
ISSN du journal2326-5191
212vues
0téléchargements

Informations techniques

Création07.11.2019 10:17:00
Première validation07.11.2019 10:17:00
Heure de mise à jour15.03.2023 18:39:38
Changement de statut15.03.2023 18:39:36
Dernière indexation17.01.2024 08:39:04
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack